Cell-free tumor DNA analysis in advanced or metastatic breast cancer patients: mutation frequencies, testing intention, and clinical impact.
Huebner H, Wimberger P, Laakmann E, Ruckhäberle E, Ruebner M, Lehle S, Uhrig S, Ziegler P, Link T, Hack CC, Belleville E, Faull I, Hausch M, Wallwiener D, Schneeweiss A, Tesch H, Brucker SY, Beckmann MW, Fasching PA, Müller V, Fehm TN.
Huebner H, et al. Among authors: muller v.
Precis Clin Med. 2024 Dec 24;8(1):pbae034. doi: 10.1093/pcmedi/pbae034. eCollection 2025 Mar.
Precis Clin Med. 2024.
PMID: 39839709
Free PMC article.